SwePub
Sök i SwePub databas

  Utökad sökning

Träfflista för sökning "WFRF:(Normark Birgitta Henriques) srt2:(2020-2023)"

Sökning: WFRF:(Normark Birgitta Henriques) > (2020-2023)

  • Resultat 1-8 av 8
Sortera/gruppera träfflistan
   
NumreringReferensOmslagsbildHitta
1.
  • Bletsa, Eleni, et al. (författare)
  • Highly durable photocatalytic titanium suboxide–polymer nanocomposite films with visible light-triggered antibiofilm activity
  • 2023
  • Ingår i: Chemical Engineering Journal. - : Elsevier BV. - 1385-8947 .- 1873-3212. ; 454, part 1
  • Tidskriftsartikel (refereegranskat)abstract
    • Bacterial biofilms on medical devices may result in infections with significant societal burden. One drug-free strategy against biofilms is photocatalysis, in which a semiconducting coating is applied on the medical device and irradiated with light to generate reactive oxygen species providing an on-demand disinfection approach. However, most photocatalytic materials are active in the harmful UV range rendering them unsuitable for biomedical applications. Furthermore, the main manufacturing bottleneck today for antibiofilm coatings is their poor durability. To address these challenges, here we produced silver/titanium-suboxide nanoparticles that are photocatalytically active in the visible-light range. Moreover, we directly deposited the nanoparticles as porous coatings on substrates in situ during their aerosol synthesis. To enhance their durability, we infused the fabricated porous coatings with a polymer solution barely covering the photocatalytic particle film, resulting in the formation of polymer nanocomposite coatings. The optimized polymer nanocomposite films exhibit several cycles of triggered, on-demand biofilm eradication activity under short visible light illumination of 15–90 min with no significant intrinsic cytotoxicity to mammalian cells. The developed films can be considered as a suitable coating material for medical devices, such as catheters, ventilators, wound meshes, and others, that may require repeated disinfection during use.
  •  
2.
  • Reithuber, Elisabeth, et al. (författare)
  • THCz : Small molecules with antimicrobial activity that block cell wall lipid intermediates
  • 2021
  • Ingår i: Proceedings of the National Academy of Sciences of the United States of America. - : National Academy of Sciences of the United States of America. - 0027-8424 .- 1091-6490. ; 118:47
  • Tidskriftsartikel (refereegranskat)abstract
    • Emerging antibiotic resistance demands identification of novel antibacterial compound classes. A bacterial whole-cell screen based on pneumococcal autolysin-mediated lysis induction was developed to identify potential bacterial cell wall synthesis inhibitors. A hit class comprising a 1-amino substituted tetrahydrocarbazole (THCz) scaffold, containing two essential amine groups, displayed bactericidal activity against a broad range of gram-positive and selected gram-negative pathogens in the low micromolar range. Mode of action studies revealed that THCz inhibit cell envelope synthesis by targeting undecaprenyl pyrophosphate-containing lipid intermediates and thus simultaneously inhibit peptidoglycan, teichoic acid, and polysaccharide capsule biosynthesis. Resistance did not readily develop in vitro, and the ease of synthesizing and modifying these small molecules, as compared to natural lipid II-binding antibiotics, makes THCz promising scaffolds for development of cell wall-targeting antimicrobials.
  •  
3.
  • Reithuber, Elisabeth, et al. (författare)
  • The Bactericidal Fatty Acid Mimetic 2CCA-1 Selectively Targets Pneumococcal Extracellular Polyunsaturated Fatty Acid Metabolism
  • 2020
  • Ingår i: mBio. - : American Society for Microbiology. - 2161-2129 .- 2150-7511. ; 11:6
  • Tidskriftsartikel (refereegranskat)abstract
    • Streptococcus pneumoniae, a major cause of pneumonia, sepsis, and meningitis worldwide, has the nasopharynges of small children as its main ecological niche. Depletion of pneumococci from this niche would reduce the disease burden and could be achieved using small molecules with narrow-spectrum antibacterial activity. We identified the alkylated dicyclohexyl carboxylic acid 2CCA-1 as a potent inducer of autolysin-mediated lysis of S. pneumoniae, while having low activity against Staphylococcus aureus. 2CCA-1-resistant strains were found to have inactivating mutations in fakB3, known to be required for uptake of host polyunsaturated fatty acids, as well as through inactivation of the transcriptional regulator gene fabT, vital for endogenous, de novo fatty acid synthesis regulation. Structure activity relationship exploration revealed that, besides the central dicyclohexyl group, the fatty acid-like structural features of 2CCA-1 were essential for its activity. The lysis-inducing activity of 2CCA-1 was considerably more potent than that of free fatty acids and required growing bacteria, suggesting that 2CCA-1 needs to be metabolized to exert its antimicrobial activity. Total lipid analysis of 2CCA-1 treated bacteria identified unique masses that were modeled to 2CCA-1 containing lysophosphatidic and phosphatidic acid in wild-type but not in fakB3 mutant bacteria. This suggests that 2CCA-1 is metabolized as a fatty acid via FakB3 and utilized as a phospholipid building block, leading to accumulation of toxic phospholipid species. Analysis of FabT-mediated fakB3 expression elucidates how the pneumococcus could ensure membrane homeostasis and concurrent economic use of host-derived fatty acids.IMPORTANCE Fatty acid biosynthesis is an attractive antibiotic target, as it affects the supply of membrane phospholipid building blocks. In Streptococcus pneumoniae, it is not sufficient to target only the endogenous fatty acid synthesis machinery, as uptake of host fatty acids may bypass this inhibition. Here, we describe a small-molecule compound, 2CCA-1, with potent bactericidal activity that upon interactions with the fatty acid binding protein FakB3, which is present in a limited number of Gram-positive species, becomes metabolized and incorporated as a toxic phospholipid species. Resistance to 2CCA-1 developed specifically in fakB3 and the regulatory gene fabT. These mutants reveal a regulatory connection between the extracellular polyunsaturated fatty acid metabolism and endogenous fatty acid synthesis in S. pneumoniae, which could ensure balance between efficient scavenging of host polyunsaturated fatty acids and membrane homeostasis. The data might be useful in the identification of narrow-spectrum treatment strategies to selectively target members of the Lactobacillales such as S. pneumoniae.
  •  
4.
  • Sender, Vicky, et al. (författare)
  • Capillary leakage provides nutrients and antioxidants for rapid pneumococcal proliferation in influenza-infected lower airways
  • 2020
  • Ingår i: Proceedings of the National Academy of Sciences of the United States of America. - : Proceedings of the National Academy of Sciences. - 0027-8424 .- 1091-6490. ; 117:49, s. 31386-31397
  • Tidskriftsartikel (refereegranskat)abstract
    • Influenza A virus (IAV)-related mortality is often due to secondary bacterial infections, primarily by pneumococci. Here, we study how IAV-modulated changes in the lungs affect bacterial replication in the lower respiratory tract (LRT). Bronchoalveolar lavages (BALs) from coinfected mice showed rapid bacterial proliferation 4 to 6 h after pneumococcal challenge. Metabolomic and quantitative proteomic analyses demonstrated capillary leakage with efflux of nutrients and antioxidants into the alveolar space. Pneumococcal adaptation to IAV-induced inflammation and redox imbalance increased the expression of the pneumococcal chaperone/protease HtrA. Presence of HtrA resulted in bacterial growth advantage in the IAV-infected LRT and protection from complement-mediated opsonophagocytosis due to capsular production. Absence of HtrA led to growth arrest in vitro that was partially restored by antioxidants. Pneumococcal ability to grow in the IAV-infected LRT depends on the nutrient-rich milieu with increased levels of antioxidants such as ascorbic acid and its ability to adapt to and cope with oxidative damage and immune clearance.
  •  
5.
  • Block, Nils, et al. (författare)
  • Bacterial meningitis : Aetiology, risk factors, disease trends and severe sequelae during 50 years in Sweden
  • 2022
  • Ingår i: Journal of Internal Medicine. - : John Wiley & Sons. - 0954-6820 .- 1365-2796. ; 292:2, s. 350-364
  • Tidskriftsartikel (refereegranskat)abstract
    • Background Bacterial meningitis (BM) is a rare but severe infection. Few population-based studies have characterised BM episodes and sequelae over long periods.Methods This was a population-based observational cohort study with national coverage, using data on aetiological pathogens, sex, premorbid conditions, steroid pretreatment, severe sequelae and birth, death and diagnosis dates collected from 10,339 patients with BM reported to the National Board of Health and Welfare in Sweden between 1964 and 2014.Results During the 50-year study period, the incidence of BM decreased in young children, but not in the elderly. The most common cause of BM was pneumococci (34%), followed by Haemophilus influenzae (26%), and meningococci (18%), mainly community acquired. Premorbid conditions were found in 20%. After the H. influenzae type b vaccine was introduced in 1993, the BM incidence decreased by 36%. Following pneumococcal conjugated vaccine introduction in 2009, the incidence and 30-day mortality from pneumococcal meningitis decreased by 64% and 100%, respectively, in previously healthy children, and the 30-day mortality decreased by 64% among comorbid adults. The BM incidence in immunosuppressed patients increased by 3% annually post vaccine introduction. The 30-day mortality was 3% in children and 14% in adults, and the rate of severe sequelae was 44%. On average, patients lost 11 years of healthy life due to BM.Conclusion The introduction of conjugated vaccines into the childhood vaccination program has reduced the incidence of BM in young children, but not in adults. Post vaccine introduction, patients present with more premorbid conditions and other bacterial causes of BM, emphasising the need for a correct diagnosis when treating these infections.
  •  
6.
  • Jackmann, Natalja, et al. (författare)
  • The human cathelicidin hCAP-18 in serum of children with haemato-oncological diseases
  • 2022
  • Ingår i: British Journal of Haematology. - : John Wiley & Sons. - 0007-1048 .- 1365-2141. ; 198:6, s. 1023-1031
  • Tidskriftsartikel (refereegranskat)abstract
    • The human cathelicidin hCAP-18 (pro-LL-37) is the pro-protein of the antimicrobial peptide LL-37. hCAP-18 can be produced by many different cell types; bone marrow neutrophil precursors are the main source of hCAP-18 in the circulation. Neutrophil count is used as a marker for myelopoiesis but does not always reflect neutrophil production in the bone marrow, and thus additional markers are needed. In this study, we established the reference interval of serum hCAP-18 level in healthy children and compared serum hCAP-18 levels between different diagnostic groups of children with haemato-oncological diseases, at diagnosis. We found that children with diseases that impair myelopoiesis, such as acute leukaemia, aplastic anaemia, or myelodysplastic syndrome, presented with low hCAP-18 levels, whereas patients with non-haematological malignancies displayed serum hCAP-18 levels in the same range as healthy children. Children with chronic myeloid leukaemia presented with high circulating levels of hCAP-18, probably reflecting the high number of all differentiation stages of myeloid cells. We suggest that analysis of serum hCAP-18 provides additional information regarding myelopoiesis in children with haemato-oncological diseases, which may have future implications in assessment of myelopoiesis in clinical management.
  •  
7.
  • Tabusi, Mahebali, et al. (författare)
  • Neuronal death in pneumococcal meningitis is triggered by pneumolysin and RrgA interactions with beta-actin
  • 2021
  • Ingår i: PLoS Pathogens. - : Public Library of Science (PLoS). - 1553-7366 .- 1553-7374. ; 17:3
  • Tidskriftsartikel (refereegranskat)abstract
    • Neuronal damage is a major consequence of bacterial meningitis, but little is known about mechanisms of bacterial interaction with neurons leading to neuronal cell death. Streptococcus pneumoniae (pneumococcus) is a leading cause of bacterial meningitis and many survivors develop neurological sequelae after the acute infection has resolved, possibly due to neuronal damage. Here, we studied mechanisms for pneumococcal interactions with neurons. Using human primary neurons, pull-down experiments and mass spectrometry, we show that pneumococci interact with the cytoskeleton protein beta-actin through the pilus-1 adhesin RrgA and the cytotoxin pneumolysin (Ply), thereby promoting adhesion and invasion of neurons, and neuronal death. Using our bacteremia-derived meningitis mouse model, we observe that RrgA- and Ply-expressing pneumococci co-localize with neuronal beta-actin. Using purified proteins, we show that Ply, through its cholesterol-binding domain 4, interacts with the neuronal plasma membrane, thereby increasing the exposure on the outer surface of beta-actin filaments, leading to more beta-actin binding sites available for RrgA binding, and thus enhanced pneumococcal interactions with neurons. Pneumococcal infection promotes neuronal death possibly due to increased intracellular Ca2+ levels depending on presence of Ply, as well as on actin cytoskeleton disassembly. STED super-resolution microscopy showed disruption of beta-actin filaments in neurons infected with pneumococci expressing RrgA and Ply. Finally, neuronal death caused by pneumococcal infection could be inhibited using antibodies against beta-actin. The generated data potentially helps explaining mechanisms for why pneumococci frequently cause neurological sequelae. Author summary Neuronal damage is a major consequence of meningitis. Streptococcus pneumoniae (pneumococcus) is the leading etiological cause of bacterial meningitis, yet how pneumococci interact with neurons and cause neuronal death is poorly understood. Using human neurons in vitro and our established bacteremia-derived meningitis mouse model in vivo, we found that pneumococci use the pilus-1 adhesin RrgA and the cytotoxin pneumolysin (Ply) to interact with neuronal beta-actin expressed on the plasma membrane. Also, we demonstrate that Ply interaction with the neuronal plasma membrane increase the exposure of beta-actin on the neuronal plasma membrane, allowing more pneumococci to adhere to neurons through RrgA-beta-actin interaction. Moreover, neurons infected with RrgA- and Ply-expressing pneumococci showed increased intracellular Ca2+ levels and disruption of beta-actin filaments, possibly leading to neuronal death. Importantly, by blocking pneumococcal-beta-actin interaction using antibodies, we could reduce neuronal cell death after pneumococcal infection.
  •  
8.
  • Van Assche, David, et al. (författare)
  • Gradient acoustic focusing of sub-micron particles for separation of bacteria from blood lysate
  • 2020
  • Ingår i: Scientific Reports. - : Springer Science and Business Media LLC. - 2045-2322. ; 10:1
  • Tidskriftsartikel (refereegranskat)abstract
    • Handling of submicron-sized objects is important in many biochemical and biomedical applications, but few methods today can precisely manipulate this range of particles. We present gradient acoustic focusing that enables flow-through particle separation of submicron particles and cells and we apply it for separation of bacteria from blood lysate to facilitate their detection in whole blood for improved diagnostics. To control suspended objects below the classical 2µm size limit for acoustic focusing, we introduce a co-flowing acoustic impedance gradient to generate a stabilizing acoustic volume force that supresses acoustic streaming. The method is validated theoretically and experimentally using polystyrene particles, Staphylococcus aureus, Streptococcus pneumoniae and Escherichia coli. The applicability of the method is demonstrated by the separation of bacteria from selectively chemically lysed blood. Combined with downstream operations, this new approach opens up for novel methods for sepsis diagnostics.
  •  
Skapa referenser, mejla, bekava och länka
  • Resultat 1-8 av 8
Typ av publikation
tidskriftsartikel (8)
Typ av innehåll
refereegranskat (8)
Författare/redaktör
Henriques-Normark, B ... (8)
Normark, Staffan (4)
Mellroth, Peter (3)
Reithuber, Elisabeth (3)
Almqvist, Fredrik (2)
Lindgren, Anders E. ... (2)
visa fler...
Widengren, Jerker (2)
Nannapaneni, Priyank ... (2)
Harila-Saari, Arja H ... (1)
Laurell, Thomas (1)
Wagner, Philippe (1)
Makitie, Outi (1)
Ohlsson, Pelle (1)
Thersleff, Thomas, 1 ... (1)
Naucler, Pontus (1)
Augustsson, Per (1)
Muschiol, Sandra (1)
Eriksson, Anna U. (1)
Qiu, Wei (1)
Bergstrand, Jan (1)
Uvell, Hanna (1)
Venugopal Srambickal ... (1)
Bletsa, Eleni (1)
Merkl, Padryk (1)
Sotiriou, Georgios A ... (1)
Block, Nils (1)
Morfeldt, Eva (1)
Schneider, Tanja (1)
Pathak, Anuj (1)
Pütsep, Katrin (1)
Iovino, Federico (1)
Rzhepishevska, Olena ... (1)
Sender, Vicky (1)
Hentrich, Karina (1)
Wixe, Torbjörn (1)
Mortberg, Anette (1)
Frisk, Per, 1966- (1)
Lundstrom, Susanna L ... (1)
Utriainen, Pauliina (1)
Jackmann, Natalja (1)
Englund, Sofia (1)
Gaetani, Massimilian ... (1)
Minoia, Melania (1)
Embaie, Bethel Tesfa ... (1)
Ludwig, Kevin C. (1)
Muller, Anna (1)
Grein, Fabian (1)
Ilchenko, Oleksandr (1)
Ler, Alicia Tan Qian (1)
Nakamoto, Rei (1)
visa färre...
Lärosäte
Karolinska Institutet (8)
Umeå universitet (2)
Kungliga Tekniska Högskolan (2)
Uppsala universitet (2)
Stockholms universitet (2)
Lunds universitet (1)
Språk
Engelska (8)
Forskningsämne (UKÄ/SCB)
Medicin och hälsovetenskap (6)
Naturvetenskap (3)
Teknik (1)

År

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy